Moleculin Biotech Inc. (NASDAQ: MBRX) Stock Information | RedChip

Moleculin Biotech Inc. (NASDAQ: MBRX) Listen to this Section

$2.42
+0.1850 ( +8.30% ) 76.9K

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The company's lead program, Annamycin is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Market Data

Open

$2.42

Previous close

$2.23

Volume

76.9K

Market cap

$6.25M

Day range

$1.48 - $2.44

52 week range

$1.48 - $15.75

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings

Form Type Description Pages Date
4 Insider transactions 1 Dec 27, 2023
4 Insider transactions 1 Dec 27, 2023
4 Insider transactions 1 Dec 27, 2023
8-k 8K-related 21 Dec 21, 2023
8-k 8K-related 17 Dec 18, 2023
8-k 8K-related 16 Dec 11, 2023
8-k 8K-related 27 Dec 11, 2023
8-k 8K-related 17 Nov 20, 2023
8-k 8K-related 41 Nov 13, 2023
8-k 8K-related 16 Nov 13, 2023

Latest News

Terms and Agreement

Please agree to the terms to continue using the chat feature.

About US

Services

Stay Connected